Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort
Last Updated: Wednesday, November 22, 2023
Background: Epidemio-Strategy-Medico-Economical-Metastatic Breast Cancer (ESME-MBC) database, a multicenter, national, observational cohort, provides recent data that provides strong evidence on the dismal prognosis, higher treatment resistance, and major unmet medical needs associated with early relapsed metastatic triple-negative breast cancer.
Advertisement
News & Literature Highlights